Delivery Order SPE2DE22D0008-SPE2D625F2NJT
Award Date 9/4/25
Potential Completion Date 11/7/25
Potential Value $6.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60607, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Alba Bioscience, Inc. was awarded a delivery order contract by the Defense Logistics Agency's Medical Supply Chain division on August 14, 2025, for the supply of ALBACLONE Anti-D Blend, a specialized blood bank reagent used in immunohematology testing. This firm fixed-price contract carries a ceiling value of $1,464.00 with an ultimate completion date of August 19, 2025. The contract was awarded on a non-competitive basis with no set-aside designation, reflecting Alba Bioscience's established...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order contract to Alba Bioscience, Inc. for ALBACLONE anti-FYB antibody screening products. The contract, valued at $12,875 with a firm fixed price structure, was executed on September 4, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside award represents a continuation of Alba Bioscience's established role as a critical supplier of specialized in vitro diagnostic...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $2,370.00 to Alba Bioscience, Inc. for ALBACLONE Anti-A antibodies, with performance completion targeted for August 19, 2025. This non-set-aside contract represents a firm fixed price delivery order for specialized blood banking diagnostic reagents to be delivered to Chicago, Illinois. Alba Bioscience, a foreign-owned subsidiary of Quotient Biodiagnostics, Inc., has established itself as a critical...
- This is a delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain division to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various U.S. government agencies. The contract, valued at $10,683.00, is for the delivery of ALBACYTE antibody identification panels and is a firm fixed-price agreement with a completion date...
- This federal contract award is for the delivery of ALBACYTE antibody screening (3-cell) products to the Defense Logistics Agency (DLA). The contract, valued at $1,281.00, was awarded to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, and other biomedical products to various federal agencies, including the Department of Veterans Affairs (VA) and the Department of Health and Human Services (HHS). The...
- This is a federal contract award to Alba Bioscience, Inc., a for-profit organization based in Chicago, Illinois, that specializes in the production and distribution of in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials for federal healthcare systems. The contract, worth $1,118.00, is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 22, 2025. The contract is funded by the Defense Logistics Agency (DLA),...
- This federal contract award, with the ID SPE2DE22D0008|SPE2D624F7DW1, was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials. The $1,906.00 firm-fixed-price contract is for the delivery of ALBACYTE antibody screening (3-cell) products, with a period of performance ending on October 8, 2024. Alba Bioscience is a...
- This is a federal contract award to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics and blood banking products. The contract, worth $1,740.00, is a delivery order under contract SPE2DE22D0008|SPE2D625F15SJ, awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain. The contract is for the supply of ALBACYTE Antibody ID Panels, which are specialized 16-cell panels used for antibody identification in blood banking operations. This contract does...
- Alba Bioscience, Inc., a Chicago-based subsidiary of Quotient Biodiagnostics specializing in blood bank reagents and in vitro diagnostic products, has been awarded a Blanket Purchase Agreement (BPA) Call with a ceiling value of $47,270.87 for Quotient blood bank transfusion reagents. The award, issued on June 1, 2024, is funded by Veterans Integrated Service Network 19, a component of the Department of Veterans Affairs, with an ultimate completion date of May 31, 2025. This contract is...
- This federal contract award to Alba Bioscience, Inc., a subsidiary of Quotient Biodiagnostics, Inc., is for the delivery of ALBACLONE anti-B medical supplies. The $3,792.00 Firm Fixed Price contract was awarded on May 16, 2025 by the Defense Logistics Agency (DLA), a defense agency, with a completion date of May 21, 2025. The contract is not designated as a set-aside. Alba Bioscience, Inc. is a for-profit organization specializing in in vitro diagnostics, blood bank reagents, and other...